Skip to main content

Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks.

Publication ,  Journal Article
Reamy, BV; Viera, AJ
Published in: FP Essent
September 2022

Diabetes, hypertension, tobacco use, and obesity each substantially increases the risk of cardiovascular disease (CVD) and must be controlled as part of CVD prevention. Among patients with diabetes, the reduction of CVD risk from lower A1c goals must be balanced against the risks of hypoglycemia. The American Diabetes Association (ADA) recommends an A1c goal for adults of less than 7% if hypoglycemia can be avoided. A less stringent goal of less than 8% is appropriate in patients with limited life expectancy. A blood pressure (BP) goal of less than 140/90 mm Hg is prudent for all adults younger than 60 years. A goal of less than 140/90 mm Hg also is advised for initiating or intensifying pharmacotherapy in adults 60 years and older with a history of stroke or who are at high cardiovascular risk. BP targets should be individualized to balance the known benefits of lowering BP to 120/80 mm Hg with the risks of morbidity because of hypotension and adverse effects. Varenicline is the most effective drug for smoking cessation, and abstinence rates are increased by combining it with nicotine replacement therapy. Bariatric surgery is the most effective management for long-term weight loss and reduction of obesity-related comorbidities. Social drivers of health are the primary cause of CVD outcomes differences among races and ethnicities.

Duke Scholars

Published In

FP Essent

ISSN

2159-3000

Publication Date

September 2022

Volume

520

Start / End Page

26 / 31

Location

United States

Related Subject Headings

  • Tobacco Use Cessation Devices
  • Smoking Cessation
  • Obesity
  • Hypoglycemia
  • Humans
  • Glycated Hemoglobin
  • Cardiovascular Diseases
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reamy, B. V., & Viera, A. J. (2022). Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks. FP Essent, 520, 26–31.
Reamy, Brian V., and Anthony J. Viera. “Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks.FP Essent 520 (September 2022): 26–31.
Reamy BV, Viera AJ. Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks. FP Essent. 2022 Sep;520:26–31.
Reamy, Brian V., and Anthony J. Viera. “Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks.FP Essent, vol. 520, Sept. 2022, pp. 26–31.
Reamy BV, Viera AJ. Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks. FP Essent. 2022 Sep;520:26–31.

Published In

FP Essent

ISSN

2159-3000

Publication Date

September 2022

Volume

520

Start / End Page

26 / 31

Location

United States

Related Subject Headings

  • Tobacco Use Cessation Devices
  • Smoking Cessation
  • Obesity
  • Hypoglycemia
  • Humans
  • Glycated Hemoglobin
  • Cardiovascular Diseases
  • Adult